HomeInsightsStock Comparison

Albert David Ltd vs J B Chemicals Pharmaceuticals Ltd Stock Comparison

Albert David Ltd vs J B Chemicals Pharmaceuticals Ltd Stock Comparison

Last Updated on: Aug 21, 2025

Key Highlights

  • The Latest Trading Price of Albert David Ltd is ₹ 817.75 as of 21 Aug 15:30.
  • The P/E Ratio of Albert David Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of J B Chemicals & Pharmaceuticals Ltd changed from 14.4 on March 2020 to 38.3 on March 2025 . This represents a CAGR of 17.71% over 6 years.
  • The Market Cap of Albert David Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 3928 crore on March 2020 to ₹ 25253 crore on March 2025 . This represents a CAGR of 36.36% over 6 years.
  • The revenue of Albert David Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of J B Chemicals & Pharmaceuticals Ltd for the Jun '25 is ₹ 1108 crore as compare to the Mar '25 revenue of ₹ 963.96 crore. This represent the growth of 14.99%.
  • The ebitda of Albert David Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of J B Chemicals & Pharmaceuticals Ltd for the Jun '25 is ₹ 315.42 crore as compare to the Mar '25 ebitda of ₹ 240.92 crore. This represent the growth of 30.92%.
  • The net profit of Albert David Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 142.32 crore to ₹ 202.38 crore over 9 quarters. This represents a CAGR of 16.94% .
  • The Dividend Payout of Albert David Ltd changed from 20.85 % on March 2020 to 16.6 % on March 2025 . This represents a CAGR of -3.73% over 6 yearsThe Dividend Payout of J B Chemicals & Pharmaceuticals Ltd changed from 31.71 % on March 2020 to 36.98 % on March 2025 . This represents a CAGR of 2.60% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Albert David Ltd

  • Albert David Limited (ADL), a Unit of Kothari Group, was incorporated in 1938 at Calcutta.
  • The Company belongs to a renowned industrial house of Kolkata, the 'Kothari Group'.
  • The Company's principal business is manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export.
  • Apart from these, it manufactures disposable syringes and needles and a wide range of bulk drugs.
  • It is recognised as a large IV fluid manufacturer, both in glass and polyethylene containers. ADL has entered into a technical collaboration with Morishita Pharmaceuticals, Japan, a subsidiary of Ajinomoto -- the world leader in amino acids -- to manufacture amino acid infusions, for which it came out with a rights issue in Aug.'87.

About J B Chemicals & Pharmaceuticals Ltd

  • J B Chemicals & Pharmaceuticals Limited (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals on December 18, 1976.
  • The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and Active Pharmaceutical Ingredients (APIs).
  • The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman.
  • The bulk drug plant at Panoli and formulation plant at Daman became operational in Apr.'95.
  • Products like metrogyl, rantac (a ranitidine-based formulation), and nicardia (a cardiac care medicine) form a significant part of the company's sales.

Albert David Ltd News Hub

News

Albert David to declare Quarterly Results

Albert David will hold a meeting of the Board of Directors of the Company on 2 August 2025...

Read more

26 Jul 2025 09:49

News

Board of Albert David recommends final dividend

Albert David announced that the Board of Directors of the Company at its meeting held on 1...

Read more

14 May 2025 09:11

News

Albert David schedules AGM

Albert David announced that the 86th Annual General Meeting(AGM) of the company will be he...

Read more

14 May 2025 09:11

News

Albert David Ltd leads losers in 'B' group

Mafatlal Industries Ltd, Sportking India Ltd, Platinum Industries Ltd and IKIO Technologie...

Read more

14 May 2025 14:45

News

Albert David schedules board meeting

Albert David will hold a meeting of the Board of Directors of the Company on 13 May 2025. ...

Read more

08 May 2025 11:20

News

Albert David schedules board meeting

Albert David will hold a meeting of the Board of Directors of the Company on 13 May 2025. ...

Read more

07 May 2025 10:54

J B Chemicals & Pharmaceuticals Ltd News Hub

News

J B Chemicals & Pharmaceuticals allots 1.14 lakh equity shares under ESOS

J B Chemicals & Pharmaceuticals has allotted 114,999 equity shares under ESOS on 14 August...

Read more

14 Aug 2025 15:34

News

J B Chemicals & Pharmaceuticals allots 23,003 equity shares under ESOS

J B Chemicals & Pharmaceuticals has allotted 23,003 equity shares under ESOS on 09 August ...

Read more

11 Aug 2025 17:36

News

J B Chemicals & Pharmaceuticals Ltd eases for fifth straight session

J B Chemicals & Pharmaceuticals Ltd dropped for a fifth straight session today. The stock ...

Read more

05 Aug 2025 13:35

News

JB Chemicals Q1 PAT jumps 14% YoY to Rs 202 cr

Profit before tax (PBT) stood at Rs 271.61 crore in Q1 FY26, rising 13.25% from the Rs 239...

Read more

31 Jul 2025 11:27

News

J B Chemicals & Pharmaceuticals Ltd soars 1.07%, up for fifth straight session

J B Chemicals & Pharmaceuticals Ltd is up for a fifth straight session in a row. The stock...

Read more

25 Jul 2025 13:00

News

J B Chemicals & Pharmaceuticals to discuss results

J B Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

22 Jul 2025 10:13

SWOT Analysis Of Albert David Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of J B Chemicals & Pharmaceuticals Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Albert David Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for J B Chemicals & Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Albert David Ltd and J B Chemicals & Pharmaceuticals Ltd

Which company has a larger market capitalization, Albert David Ltd or J B Chemicals & Pharmaceuticals Ltd?

Market cap of Albert David Ltd is 466 Cr while Market cap of J B Chemicals & Pharmaceuticals Ltd is 26,987 Cr

What are the key factors driving the stock performance of Albert David Ltd and J B Chemicals & Pharmaceuticals Ltd?

The stock performance of Albert David Ltd and J B Chemicals & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Albert David Ltd and J B Chemicals & Pharmaceuticals Ltd?

As of August 21, 2025, the Albert David Ltd stock price is INR ₹817.75. On the other hand, J B Chemicals & Pharmaceuticals Ltd stock price is INR ₹1726.2.

How do dividend payouts of Albert David Ltd and J B Chemicals & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Albert David Ltd and J B Chemicals & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions